Translate to...

Gilead says additional data on remdesivir shows improved clinical recovery

Gilead says additional data on remdesivir shows improved clinical recovery
Gilead says additional data on remdesivir shows improved clinical recovery Findings from an analysis of its late-stage study showed that 74.4 percent of remdesivir-treated patients recovered by Day 14 versus 59.0 percent of patients receiving standard of care, the company said.